Feb 12 (Reuters) - Ipsen SA IPN.PA:
IPSEN FY REVENUE EUR 3,675.9 MILLION VERSUS. IBES ESTIMATE EUR 3,785 MILLION
IPSEN FY ADJUSTED EPS EUR 12.09 VERSUS. IBES ESTIMATE EUR 11.2
IPSEN FY ADJUSTED EBIT MARGIN 35.2%
IPSEN FY EPS EUR 5.32
IPSEN FY EBIT MARGIN 17%
IPSEN SA - OUTLOOK 2026: TOTAL SALES GROWTH GREATER THAN 13.0% AT CER
IPSEN SA - OUTLOOK 2026: CORE OPERATING MARGIN GREATER THAN 35.0% OF TOTAL SALES
IPSEN SA - WE ANTICIPATE FIVE REGULATORY AND CLINICAL MILESTONES THIS YEAR AND TO FURTHER DELIVER ON OUR EXTERNAL INNOVATION STRATEGY - CEO
IPSEN SA - NO LONGER EXPECTS TO ACHIEVE EUR 500M PEAK SALES FOR ONIVYDE AND TAZVERIK
IPSEN SA - IS HIGHLY CONFIDENT ON ITS 2027 MID-TERM OUTLOOK TO EXCEED TOTAL-SALES AVERAGE GROWTH OF AT LEAST 7% PER YEAR FOR PERIOD 2023-27
IPSEN SA - CONFIRMS TARGET OF CORE OPERATING MARGIN IN 2027 OF AT LEAST 32% OF TOTAL SALES
Source text: ID:nGNEb7yqqS
Further company coverage: IPN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))